241 related articles for article (PubMed ID: 25546405)
1. Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.
Obry A; Lequerré T; Hardouin J; Boyer O; Fardellone P; Philippe P; Le Loët X; Cosette P; Vittecoq O
PLoS One; 2014; 9(12):e115800. PubMed ID: 25546405
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort.
Smith SL; Plant D; Eyre S; Hyrich K; Morgan AW; Wilson AG; Isaacs JD; Barton A
Rheumatology (Oxford); 2017 Jun; 56(6):1019-1024. PubMed ID: 28096457
[TBL] [Abstract][Full Text] [Related]
3. Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
Yasar O; Akcay T; Obek C; Turegun FA
Scand J Clin Lab Invest; 2017 Oct; 77(6):437-441. PubMed ID: 28609200
[TBL] [Abstract][Full Text] [Related]
4. Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy.
Rodriguez-Jimenez NA; Garcia-Gonzalez CE; Ayala-Lopez KP; Trujillo-Hernandez B; Aguilar-Chavez EA; Rocha-Muñoz AD; Vasquez-Jimenez JC; Olivas-Flores E; Salazar-Paramo M; Corona-Sanchez EG; Vazquez-Del Mercado M; Varon-Villalpando E; Cota-Sanchez A; Cardona-Muñoz EG; Gamez-Nava JI; Gonzalez-Lopez L
Biomed Res Int; 2014; 2014():510305. PubMed ID: 25243145
[TBL] [Abstract][Full Text] [Related]
5. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI
Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911
[TBL] [Abstract][Full Text] [Related]
6. Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination.
Vittecoq O; Guillou C; Hardouin J; Gerard B; Berenbaum F; Constantin A; Rincheval N; Combe B; Lequerre T; Cosette P
Arthritis Res Ther; 2022 Mar; 24(1):72. PubMed ID: 35313956
[TBL] [Abstract][Full Text] [Related]
7. Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy.
Gernert M; Schmalzing M; Tony HP; Strunz PP; Schwaneck EC; Fröhlich M
Arthritis Res Ther; 2022 Aug; 24(1):200. PubMed ID: 35986420
[TBL] [Abstract][Full Text] [Related]
8. Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis.
Nys G; Cobraiville G; Servais AC; Malaise MG; de Seny D; Fillet M
Talanta; 2019 Nov; 204():507-517. PubMed ID: 31357327
[TBL] [Abstract][Full Text] [Related]
9. Formation of Calprotectin Inhibits Amyloid Aggregation of S100A8 and S100A9 Proteins.
Baronaitė I; Šulskis D; Kopu Stas A; Tutkus M; Smirnovas V
ACS Chem Neurosci; 2024 May; 15(9):1915-1925. PubMed ID: 38634811
[TBL] [Abstract][Full Text] [Related]
10. From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis.
Inciarte-Mundo J; Frade-Sosa B; Sanmartí R
Front Immunol; 2022; 13():1001025. PubMed ID: 36405711
[TBL] [Abstract][Full Text] [Related]
11. S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs.
Roszkowski L; Jaszczyk B; Plebańczyk M; Ciechomska M
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614150
[TBL] [Abstract][Full Text] [Related]
12. Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate.
Nielsen UB; Bruhn LV; Ellingsen T; Stengaard-Pedersen K; Hornung N
Scand J Clin Lab Invest; 2018; 78(1-2):62-67. PubMed ID: 29228799
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
Wakiya R; Kameda T; Ueeda K; Nakashima S; Shimada H; Mansour MF; Kato M; Miyagi T; Miyatake N; Kadowaki N; Dobashi H
Lupus; 2019 Jun; 28(7):826-833. PubMed ID: 31068068
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of biomarkers predicting the response to triple therapy in patients with rheumatoid arthritis.
Chen J; Tang MS; Xu LC; Li S; Ge Y; Du JF; Xie X; Tian J; Chen JW; Li F
Biomed Pharmacother; 2019 Aug; 116():109026. PubMed ID: 31146113
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin K
Xu W; Wu H; Tahara K; Chen S; Wang X; Tanaka S; Sugiyama K; Sawada T; Hirano T
Fundam Clin Pharmacol; 2021 Oct; 35(5):832-842. PubMed ID: 33780033
[TBL] [Abstract][Full Text] [Related]
16. Utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as biomarker to predict therapeutic response to methotrexate in rheumatoid arthritis.
Gamez-Nava JI; Bonilla-Lara D; Ponce-Guarneros JM; Zuñiga-Mora JA; Perez-Guerrero EE; Murillo-Vazquez JD; Becerra-Alvarado IN; Rodriguez-Jimenez NA; Saldaña-Cruz AM; Vazquez-Villegas ML; Vera-Navarrete EY; Gonzalez-Ponce F; Gonzalez-Lopez L
Innate Immun; 2017 Oct; 23(7):606-614. PubMed ID: 28876141
[TBL] [Abstract][Full Text] [Related]
17. Association Between Serum S100A8/S100A9 Heterodimer and Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Huang SJ; Ding ZN; Xiang HX; Fu L; Fei J
Lung; 2020 Aug; 198(4):645-652. PubMed ID: 32661658
[TBL] [Abstract][Full Text] [Related]
18. The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease.
Azramezani Kopi T; Amini Kadijani A; Parsian H; Shahrokh S; Asadzadeh Aghdaei H; Mirzaei A; Balaii H; Zali MR
Arab J Gastroenterol; 2019 Sep; 20(3):135-140. PubMed ID: 31563476
[TBL] [Abstract][Full Text] [Related]
19. S100-alarmins: potential therapeutic targets for arthritis.
Austermann J; Zenker S; Roth J
Expert Opin Ther Targets; 2017 Jul; 21(7):739-751. PubMed ID: 28494625
[TBL] [Abstract][Full Text] [Related]
20. S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy.
Razmkhah F; Kim S; Lim S; Dania AJ; Choi J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
